Clinical Trial Update: Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ARNI versus ACE inhibitor to determine superiority in reducing heart failure events after acute myocardial infarction completed; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• ACE inhibitor (angiotensin-converting enzyme inhibitor)
• ARNI

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Myocardial Infarction | Phase 3 | Status: COMPLETED | Results posted: 2023-06-22